Patrick Rowan, MD
Orthopaedic Surgery · Columbia, MONPI 1669901997
Payments from drug & device makers
Across 111 payments — averaging $323.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$23K
- Smith+Nephew$6K
- Encore Medical, LP$1K
- Elite Orthopedics, LLC$1K
- Ortho Development Corporation$1K
- DJO, LLC$637
- plus $3K from 26 others
What the payments were for
- Grants$20,34657%
- Travel & lodging$4,96114%
- Food & beverage$4,00311%
- Education$6,60018%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 31 | $22,738 |
| Smith+Nephew | 14 | $6,260 |
| Encore Medical, LP | 8 | $1,436 |
| Elite Orthopedics, LLC | 1 | $1,200 |
| Ortho Development Corporation | 3 | $1,059 |
| DJO, LLC | 2 | $637 |
| Johnson & Johnson(2 entities) | 14 | $482 |
| Stryker | 2 | $444 |
| Zimmer Biomet | 3 | $353 |
| CGG Medical Inc | 2 | $233 |
| Medical Device Business Services, Inc. | 1 | $122 |
| Coastal Medical Technologies LLC | 1 | $113 |
| Amgen | 4 | $102 |
| Biocomposites Inc | 1 | $100 |
| Prime Surgical, LLC | 1 | $99 |
| Bioventus LLC | 3 | $75 |
| Pfizer | 3 | $71 |
| Shoulder Innovations, Inc. | 1 | $58 |
| Atland Pharmaceuticals, LLC | 1 | $40 |
| Orthofix Medical, Inc. | 2 | $37 |
| Providence Medical Technology, Inc. | 1 | $30 |
| Radius Health, Inc. | 1 | $27 |
| Convatec Inc. | 1 | $26 |
| Molnlycke Health Care US, LLC | 1 | $26 |
| Kinex Medical Company LLC | 1 | $26 |
| Vertex | 1 | $22 |
| Solventum Corporation | 1 | $19 |
| Heraeus Medical, LLC. | 2 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Conmed Corporation | 1 | $16 |
| KCI USA, Inc. | 1 | $16 |
| ERMI LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DJO SURGICAL$1,257
- BKS TriMax$960
- Balanced Knee System$960
- DONJOY$548
- NONE$346
- Bioinductive Implant with Arthroscopic Delivery System - Medium$316
- Bone Anchors with Arthroscopic Delivery System$291
- G7$274
- Avenir$274
- Persona$145
- TFN-Advance$138
- LENS 4K$134
- Healicoil$134
- Oxford-Knees$129
- NA$122
How this compares
$35,910 in reported general payments places this provider in the 85th percentile of 455 orthopaedic surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 85 | $399 |
| Celecoxib | 20 | $227 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $202 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 33 | $117 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Columbia
- Matthew SmithColumbia$4M
- Kurt BormannColumbia$203K
- Bhajanjit BalColumbia$171K
- Mauricio KfuriColumbia$65K
- Jay KeenerSaint Louis$2.2M
- John WatsonSaint Louis$1.7M
- Alexandra StrongN Kansas City$1.1M
- Thomas McCormackKansas City$852K
- Michael SnyderJefferson City$676K
- Peter ChalmersSaint Louis$674K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.